Home/Filings/4/0001519749-22-000004
4//SEC Filing

Hart Jayne B. 4

Accession 0001519749-22-000004

CIK 0000899923other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:55 PM ET

Size

13.1 KB

Accession

0001519749-22-000004

Insider Transaction Report

Form 4
Period: 2022-02-28
Hart Jayne B.
Executive VP Human Resources
Transactions
  • Sale

    Common Stock

    2022-02-28$25.00/sh3,500$87,500165,878 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2022-02-283,5000 total
    Exercise: $23.98Exp: 2022-03-07Common Stock (3,500 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2022-02-287,0000 total
    Exercise: $23.98Exp: 2022-03-07Common Stock (7,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-28$23.98/sh+3,500$83,930169,378 total
  • Exercise/Conversion

    Common Stock

    2022-02-28$23.98/sh+7,000$167,860172,878 total
  • Sale

    Common Stock

    2022-02-28$25.00/sh7,000$175,000165,878 total
Footnotes (3)
  • [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]Represents shares of common stock received upon exercise of a stock option award.
  • [F3]The shares subject to this option are fully vested and exercisable.

Issuer

MYRIAD GENETICS INC

CIK 0000899923

Entity typeother

Related Parties

1
  • filerCIK 0001519749

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:55 PM ET
Size
13.1 KB